Dhansa LabsShare price, financial results, shareholding and management
- Market cap
- ₹70 cr
- Stock P/E
- 12.7peers 20.6
- Book value
- ₹30.4
- Price to book
- 0.86
- EV / operating profit
- 9.8
- Market cap to sales
- 0.49
- ROCE · FY26
- 8.4%
- ROE · FY26
- 7.0%
- ROE, 3-year average
- 15.7%
- Operating margin · FY26
- 7.7%peers 9.8%
- Sales growth, 3 years
- 10.5%
- Profit growth, 3 years
- 3.4%
- Debt to equity
- 0.48peers 0.70
- Borrowings
- ₹39.7 cr
- Interest cover
- 3.8×
- Cash from business / op. profit
- -40%
- Debtor days
- 139
- Pledged
- 0.00%
- Promoter holding
- 65.05%
- Change in promoter holding
- 0.00 pts
- Shareholders
- 1,201
- 52-week high / low
- ₹37 / ₹18
- Dividend yield
- 0.00%
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
newboard is reading this company's filings. Its plain description, key points, management and study will appear here soon; the figures below are worked out from what it has filed.
Dhansa Labs share price chart
Close on 6 Nov 2026 · -0.76% on the day · Vol 8,000
Daily prices to 6 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 6 Nov 2026
- 1 month
- -7.8%
- 3 months
- +25.3%
- Traded a day, 20 days
- ₹0.02 cr
- Taken for delivery
- 94%
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +8% | +15% |
| 3 years, a year | +11% | +3% |
Dhansa Labs revenue and profit growth
Half-yearly results · Profit and lossSales have grown steadily. Last year profit grew faster than sales, so the company kept more from each rupee of sales.
SME companies report every six months.
Dhansa Labs half-yearly results
SME companies report every six months · ₹ crore
| H2FY25 | H1FY26 | |
|---|---|---|
| Sales | 63.62 | 68.18 |
| Expenses | 59.86 | 62.28 |
| Operating profit | 3.75 | 5.89 |
| OPM | 5.9% | 8.7% |
| Interest | 0.76 | 1.92 |
| Depreciation | 1.71 | 1.10 |
| Profit before tax | 2.43 | 3.01 |
| Net profit | 1.82 | 2.62 |
Dhansa Labs profit and loss
Full years to March, FY21 to FY26 · ₹ crore, consolidated where reported
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Sales | 82 | 85 | 105 | 120 | 131.27 | 141.54 |
| Expenses | 72 | 74 | 97 | 111 | 121.69 | 130.63 |
| Operating profit | 10 | 10 | 8 | 9 | 9.58 | 10.91 |
| OPM | 12.0% | 12.0% | 7.0% | 8.0% | 7.3% | 7.7% |
| Other income | 1 | 1 | 3 | 1 | 1.92 | 1.31 |
| Interest | 4 | 3 | 2 | 2 | 2.54 | 2.62 |
| Depreciation | 3 | 3 | 3 | 2 | 2.91 | 2.20 |
| Exceptional and other items | -1 | · | · | · | · | · |
| Profit before tax | 3 | 5 | 6 | 6 | 6.04 | 7.40 |
| Tax rate | -233.3% | 20.0% | 16.7% | -33.3% | 20.9% | 25.4% |
| Net profit | 10 | 4 | 5 | 8 | 4.78 | 5.52 |
| EPS ₹ | 211.28 | 20.11 | 29.52 | 4.13 | 2.06 | 2.21 |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
The years to FY24 come rounded to the nearest crore in the source.
Exceptional and other items: profit before tax beyond operating profit, other income, interest and depreciation, such as one-off items or a share of associates' profit, as reported.
A tax rate above 60% or below zero (FY21, FY24) comes from tax charged on a small or negative profit, as reported.
Earnings per share before FY22 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.
Dhansa Labs profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a low return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Operating margin | 12.0% | 12.0% | 7.0% | 8.0% | 7.3% | 7.7% |
| Tax rate | -233.3% | 20.0% | 16.7% | -33.3% | 20.9% | 25.4% |
| ROCE | · | 25.8% | 22.9% | 16.8% | 9.6% | 8.4% |
| ROE | · | 72.7% | 26.3% | 31.4% | 8.8% | 7.0% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Dhansa Labs debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown. Its loans are smaller than its own money. Last year the business used more cash than it brought in. It spent more on assets and investments than the business brought in, and raised the rest from loans or shares. Customers take longer to pay than they did in FY24, which ties up more of the company's money in unpaid bills.
Bars below the line are cash going out.
Dhansa Labs balance sheet
At each 31 March · ₹ crore
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Equity capital | 5 | 18 | 18 | 19 | 24.95 | 24.95 |
| Reserves | -13 | 1 | 1 | 13 | 51.40 | 56.93 |
| Net worth | -8 | 19 | 19 | 32 | 76.35 | 81.87 |
| Borrowings | 33 | 18 | 14 | 30 | 40.84 | 39.67 |
| Other liabilities | 20 | 19 | 21 | 17 | 10.02 | 29.38 |
| Total liabilities | 45 | 56 | 54 | 79 | 127.21 | 150.92 |
| Fixed assets | 16 | 25 | 25 | 24 | 23.12 | 24.32 |
| Capital work in progress | 1 | 0 | 0 | 4 | 16 | 23 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 |
| Other assets | 28 | 31 | 28 | 50 | 88.09 | 103.60 |
| Receivables | · | · | · | · | 40.43 | 53.90 |
| Inventory | · | · | · | · | 29.91 | 31.54 |
| Cash | · | · | · | · | 1.76 | 2.50 |
| Trade payables | · | · | · | · | 6.63 | 6.28 |
Dhansa Labs cash flow
₹ crore
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Cash from operations | 3 | 6 | 10 | -13 | -34.48 | -4.37 |
| Cash from investing | -1 | -1 | -4 | -5 | -13.50 | -48.18 |
| Cash from financing | -1 | -5 | -6 | 18 | 48.34 | 54.02 |
| Net cash flow | 1 | 0 | 0 | 0 | 0.36 | 1.47 |
| Capital spending | · | · | · | · | 13.52 | 49.28 |
Working capital
Days
| FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|
| Debtor days | 31 | 37 | 12 | 57 | 112 | 139 |
| Inventory days | · | · | 78 | 75 | 99 | 95 |
| Days payable | · | · | 74 | 54 | 22 | 19 |
| Cash conversion cycle | 31 | 37 | 17 | 78 | 189 | 215 |
| Working capital days | -10 | 11 | 18 | 49 | 126 | 170 |
Dhansa Labs peers and competitors
Listed SME companies in the same industryBy sales, Dhansa Labs is number 6 of the 7 listed SME companies in fertilizers & agrochemicals.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Aristo Bio-Tech And Lifescience | 64 | 8.9 | 364 | 7.2 | 4.4% | 0.80 |
| Mahamaya Lifesciences | 438 | 25.7 | 329 | 17 | 10.0% | 0.75 |
| Crop Life Science | 106 | 16.3 | 207 | 6.5 | 8.6% | 0.64 |
| Anya Polytech & Fertilizers | 210 | 25.0 | 178 | 8.4 | 9.5% | 0.85 |
| Balaji Phosphates | 257 | 25.1 | 170 | 10.2 | 11.1% | 0.47 |
| Dhansa Labs | 70 | 12.7 | 142 | 5.5 | 7.7% | 0.48 |
| Shivchem Agro | 36 | 11.1 | 33.4 | 3.3 | 18.1% | 0.56 |
| Median of the 6 others | 158 | 20.7 | 193 | 7.8 | 9.8% | 0.70 |
Dhansa Labs shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company, a little less than in the first filing shown. Big foreign and Indian funds own very little. The number of shareholders has come down.
Dhansa Labs shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Sep 24 | Mar 25 | Sep 25 | Mar 26 | Apr 26 | May 26 | Jun 26 | |
|---|---|---|---|---|---|---|---|
| Promoters | 69.90% | 70.11% | 70.15% | 70.15% | 67.78% | 65.05% | 65.05% |
| Foreign investors (FIIs) | 1.46% | 0.01% | - | - | - | - | - |
| Indian institutions (DIIs) | 4.11% | 2.34% | 1.96% | 0.72% | 0.36% | 0.33% | - |
| HNIs (over ₹2 lakh each) | - | 7.67% | 7.64% | 8.09% | 9.24% | 12.96% | 12.87% |
| Small holders (up to ₹2 lakh) | - | 14.72% | 14.73% | 14.72% | 13.91% | 13.34% | 13.72% |
| Companies and others | - | 5.15% | 5.52% | 6.32% | 8.71% | 8.32% | 8.36% |
| Number of shareholders | 1,520 | 1,327 | 1,291 | 1,224 | 1,202 | 1,200 | 1,201 |
The named holders are at 30 June 2026, beside 26 May 2026, each under the group the pattern files them in.
Dhansa Labs latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- Shareholding, 30 June 2026: promoters unchanged at 65.05%.
Dhansa Labs announcements
31 on record, latest first; each opens the filing on the exchange
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September, 2026PDF ↗
- Shareholders meetingSrutinizers report of 41st Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting resultsPDF ↗
- Trading WindowClosure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF ↗
- Shareholders meetingProceedings of 41st Annual General Meeting held on September 26, 2026PDF ↗
- Shareholders meetingDisclosure under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Voting Results of the Postal Ballot and the ScrPDF ↗
- Copy of Newspaper PublicationSubmission of Notice for attention of Equity Shareholders of the Company in respect of information regarding 41st Annual General Meeting to be held on 26th SeptPDF ↗
- Shareholders meetingNotice of 41st Annual General Meeting and Annual Report for the Financial Year 2025-26PDF ↗
- Copy of Newspaper PublicationSubmission of Newspaper Advertisements for attention of Equity Shareholders of the Company in respect of information regarding the 41st Annual General Meeting tPDF ↗
- Outcome of Board MeetingHeld on August 27, 2026PDF ↗
- General UpdatesIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Groundbreaking Ceremony & Bhoomi Pujan of 15 TPPDF ↗
- General UpdatesIntimation of Receipt of Listing / Trading Approval for Allotment of Equity Shares Pursuant to Conversion of Warrants on Preferential BasisPDF ↗
- Copy of Newspaper PublicationNewspaper advertisement for the Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026PDF ↗
Dhansa Labs annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
Dhansa Labs share split, bonus and dividends
From the corporate actions the company announces on the exchange
No share split, bonus issue or dividend is on record since listing.
Checks we ran on Dhansa Labs' data · 10
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- iThe shares traded on only 79 days in the past year, so the price, its range and the returns here rest on few trades.
- iNet profit is above profit before tax in FY24: a tax credit or a share of associates' profit, as reported.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (2,69,03,340 shares).
- !The FY26 results imply 2,49,50,000 shares at face value ₹10, which disagrees with the shareholding pattern; the pattern is used.
- ✓Promoter pledge figures are within possible limits in every shareholding pattern shown.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- !Earnings per share changes basis between FY21 (₹211.28) and FY22 (₹20.11) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY21 to FY26.
- iPrices run to the close on 13 Oct 2026, from the exchange's daily figures.
Questions people ask about Dhansa Labs
What does Dhansa Labs do?
Dhansa Labs is an SME company listed on NSE Emerge, in fertilizers & agrochemicals.
What is the share price of Dhansa Labs?
₹26 at the close on 6 Nov 2026, from the exchange's daily figures.
What is the market cap of Dhansa Labs?
₹70 cr at the close on 6 Nov 2026, on 2,69,03,340 shares.
What is the P/E of Dhansa Labs?
12.7 times FY26 profit at the close on 6 Nov 2026 (our arithmetic).
What are Dhansa Labs' revenue and profit?
Revenue ₹142 cr and profit after tax ₹6 cr in FY26.
Who are the promoters of Dhansa Labs?
The promoter group; promoters held 65.05% at 30 June 2026.
What is Dhansa Labs' website?
dhansalabs.com
More SME companies like Dhansa Labs
Other listed SME companies in fertilizers & agrochemicals, the closest in size first, each read from its own documents.
- Aristo Bio-Tech And LifescienceARISTO · NSE Emerge · Fertilizers & Agrochemicals · listed 2023Market cap ₹68 cr
- Crop Life ScienceCLSL · NSE Emerge · Fertilizers & Agrochemicals · listed 2023Market cap ₹171 cr
- Anya Polytech & FertilizersANYA · NSE Emerge · Fertilizers & Agrochemicals · listed 2025Market cap ₹212 cr
- Shivchem AgroSHIVCHEM · BSE SME · Fertilizers & AgrochemicalsMarket cap ₹22 cr
- Balaji PhosphatesBALAJIPHOS · NSE Emerge · Fertilizers & Agrochemicals · listed 2025Market cap ₹300 cr
- Mahamaya LifesciencesMAHALIFE · BSE SME · Fertilizers & AgrochemicalsMarket cap ₹426 cr
Every listed SME company in Fertilizers & Agrochemicals → · SME companies listed in 2024 →
Built from 31 exchange announcements, 7 shareholding patterns and 6 years of reported results. Every figure carries its source; where the documents are silent, the page says so.